OrthoPediatrics Corp.
DE ˙ DB ˙ US68752L1008
15,50 € ↑1,50 (10,71%)
2026-06-05
AKTIENPREIS
SecurityDE:2X7 / OrthoPediatrics Corp.
InstitutionProsight Management, LP
Latest Disclosed Ownership302,399 shares
Latest Disclosed Value $ 4,799,072
Prosight Management, LP reports 121.15% increase in ownership of 2X7 / OrthoPediatrics Corp.

On May 15, 2026 - Prosight Management, LP filed a 13F-HR form disclosing ownership of 302,399 shares of OrthoPediatrics Corp. (DE:2X7) valued at $3,931,187 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 136,741 shares of OrthoPediatrics Corp.. This represents a change in shares of 121.15% during the quarter. The current value of the position is $4,687,184 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ORTHOPEDIATRICS COM 68752L100 302,399 165,658 121.15 4,799 97.65 0.7870
2026-02-13 2025-12-31 13F ORTHOPEDIATRICS COM 68752L100 136,741 -171,966 -55.71 2,429 -57.55 0.5018
2025-11-14 2025-09-30 13F ORTHOPEDIATRICS COM 68752L100 308,707 235,060 319.17 5,720 261.80 1.3341
2025-08-14 2025-06-30 13F ORTHOPEDIATRICS COM 68752L100 73,647 73,647 1,582 0.3858
2024-11-14 2024-09-30 13F ORTHOPEDIATRICS COM 68752L100 0 -200,216 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ORTHOPEDIATRICS COM 68752L100 200,216 -218,045 -52.13 5,758 -52.79 1.7211
2024-05-15 2024-03-31 13F ORTHOPEDIATRICS COM 68752L100 418,261 323,261 340.27 12,196 294.95 3.3931
2024-02-14 2023-12-31 13F ORTHOPEDIATRICS COM 68752L100 95,000 95,000 3,088 1.2399
2021-02-12 2020-12-31 13F ORTHOPEDIATRICS COM 68752L100 0 -8,399 -100.00 0 -100.00
2020-11-13 2020-09-30 13F ORTHOPEDIATRICS COM 68752L100 8,399 8,399 386 0.1836
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.